The Market Reports

Index

1 Interventional Neurology Devices Market Overview
1.1 Product Overview and Scope of Interventional Neurology Devices
1.2 Interventional Neurology Devices Segment by Type
1.2.1 Global Interventional Neurology Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Aneurysm Coiling and Embolization Devices
1.2.3 Angioplasty Devices
1.2.4 Micro Support Devices
1.2.5 Neurothrombectomy Devices
1.3 Interventional Neurology Devices Segment by Application
1.3.1 Global Interventional Neurology Devices Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Ambulatory Care Centers
1.3.4 Others
1.4 Global Interventional Neurology Devices Market Size Estimates and Forecasts
1.4.1 Global Interventional Neurology Devices Revenue 2016-2027
1.4.2 Global Interventional Neurology Devices Sales 2016-2027
1.4.3 Interventional Neurology Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Interventional Neurology Devices Market Competition by Manufacturers
2.1 Global Interventional Neurology Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Interventional Neurology Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Interventional Neurology Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Interventional Neurology Devices Manufacturing Sites, Area Served, Product Type
2.5 Interventional Neurology Devices Market Competitive Situation and Trends
2.5.1 Interventional Neurology Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Interventional Neurology Devices Players Market Share by Revenue
2.5.3 Global Interventional Neurology Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Interventional Neurology Devices Retrospective Market Scenario by Region
3.1 Global Interventional Neurology Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Interventional Neurology Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Interventional Neurology Devices Market Facts & Figures by Country
3.3.1 North America Interventional Neurology Devices Sales by Country
3.3.2 North America Interventional Neurology Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Interventional Neurology Devices Market Facts & Figures by Country
3.4.1 Europe Interventional Neurology Devices Sales by Country
3.4.2 Europe Interventional Neurology Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Interventional Neurology Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Interventional Neurology Devices Sales by Region
3.5.2 Asia Pacific Interventional Neurology Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Interventional Neurology Devices Market Facts & Figures by Country
3.6.1 Latin America Interventional Neurology Devices Sales by Country
3.6.2 Latin America Interventional Neurology Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Interventional Neurology Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Interventional Neurology Devices Sales by Country
3.7.2 Middle East and Africa Interventional Neurology Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Interventional Neurology Devices Historic Market Analysis by Type
4.1 Global Interventional Neurology Devices Sales Market Share by Type (2016-2021)
4.2 Global Interventional Neurology Devices Revenue Market Share by Type (2016-2021)
4.3 Global Interventional Neurology Devices Price by Type (2016-2021)

5 Global Interventional Neurology Devices Historic Market Analysis by Application
5.1 Global Interventional Neurology Devices Sales Market Share by Application (2016-2021)
5.2 Global Interventional Neurology Devices Revenue Market Share by Application (2016-2021)
5.3 Global Interventional Neurology Devices Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbott Interventional Neurology Devices Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 DePuy Synthes
6.2.1 DePuy Synthes Corporation Information
6.2.2 DePuy Synthes Description and Business Overview
6.2.3 DePuy Synthes Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 DePuy Synthes Interventional Neurology Devices Product Portfolio
6.2.5 DePuy Synthes Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Medtronic Interventional Neurology Devices Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Stryker
6.4.1 Stryker Corporation Information
6.4.2 Stryker Description and Business Overview
6.4.3 Stryker Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Stryker Interventional Neurology Devices Product Portfolio
6.4.5 Stryker Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Corporation Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Terumo Interventional Neurology Devices Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Acandis
6.6.1 Acandis Corporation Information
6.6.2 Acandis Description and Business Overview
6.6.3 Acandis Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Acandis Interventional Neurology Devices Product Portfolio
6.6.5 Acandis Recent Developments/Updates
6.7 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bayer Interventional Neurology Devices Product Portfolio
6.7.5 Bayer Recent Developments/Updates
6.8 Boston Scientific
6.8.1 Boston Scientific Corporation Information
6.8.2 Boston Scientific Description and Business Overview
6.8.3 Boston Scientific Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Boston Scientific Interventional Neurology Devices Product Portfolio
6.8.5 Boston Scientific Recent Developments/Updates
6.9 Biosensors International
6.9.1 Biosensors International Corporation Information
6.9.2 Biosensors International Description and Business Overview
6.9.3 Biosensors International Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Biosensors International Interventional Neurology Devices Product Portfolio
6.9.5 Biosensors International Recent Developments/Updates
6.10 evonos
6.10.1 evonos Corporation Information
6.10.2 evonos Description and Business Overview
6.10.3 evonos Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 evonos Interventional Neurology Devices Product Portfolio
6.10.5 evonos Recent Developments/Updates
6.11 Merit Medical Systems
6.11.1 Merit Medical Systems Corporation Information
6.11.2 Merit Medical Systems Interventional Neurology Devices Description and Business Overview
6.11.3 Merit Medical Systems Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Merit Medical Systems Interventional Neurology Devices Product Portfolio
6.11.5 Merit Medical Systems Recent Developments/Updates
6.12 MicroPort Scientific
6.12.1 MicroPort Scientific Corporation Information
6.12.2 MicroPort Scientific Interventional Neurology Devices Description and Business Overview
6.12.3 MicroPort Scientific Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 MicroPort Scientific Interventional Neurology Devices Product Portfolio
6.12.5 MicroPort Scientific Recent Developments/Updates
6.13 Neurosign
6.13.1 Neurosign Corporation Information
6.13.2 Neurosign Interventional Neurology Devices Description and Business Overview
6.13.3 Neurosign Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Neurosign Interventional Neurology Devices Product Portfolio
6.13.5 Neurosign Recent Developments/Updates
6.14 Penumbra
6.14.1 Penumbra Corporation Information
6.14.2 Penumbra Interventional Neurology Devices Description and Business Overview
6.14.3 Penumbra Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Penumbra Interventional Neurology Devices Product Portfolio
6.14.5 Penumbra Recent Developments/Updates
6.15 Spiegelberg
6.15.1 Spiegelberg Corporation Information
6.15.2 Spiegelberg Interventional Neurology Devices Description and Business Overview
6.15.3 Spiegelberg Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Spiegelberg Interventional Neurology Devices Product Portfolio
6.15.5 Spiegelberg Recent Developments/Updates
6.16 Surtex Instruments
6.16.1 Surtex Instruments Corporation Information
6.16.2 Surtex Instruments Interventional Neurology Devices Description and Business Overview
6.16.3 Surtex Instruments Interventional Neurology Devices Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Surtex Instruments Interventional Neurology Devices Product Portfolio
6.16.5 Surtex Instruments Recent Developments/Updates

7 Interventional Neurology Devices Manufacturing Cost Analysis
7.1 Interventional Neurology Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Interventional Neurology Devices
7.4 Interventional Neurology Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Interventional Neurology Devices Distributors List
8.3 Interventional Neurology Devices Customers

9 Interventional Neurology Devices Market Dynamics
9.1 Interventional Neurology Devices Industry Trends
9.2 Interventional Neurology Devices Growth Drivers
9.3 Interventional Neurology Devices Market Challenges
9.4 Interventional Neurology Devices Market Restraints

10 Global Market Forecast
10.1 Interventional Neurology Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Interventional Neurology Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Interventional Neurology Devices by Type (2022-2027)
10.2 Interventional Neurology Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Interventional Neurology Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Interventional Neurology Devices by Application (2022-2027)
10.3 Interventional Neurology Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Interventional Neurology Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Interventional Neurology Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Interventional Neurology Devices Sales (Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Interventional Neurology Devices Sales (Units) Comparison by Application (2021-2027)
Table 3. Global Interventional Neurology Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Interventional Neurology Devices Covered in This Study
Table 5. Global Interventional Neurology Devices Sales (Units) of Key Manufacturers (2016-2021)
Table 6. Global Interventional Neurology Devices Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Interventional Neurology Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Interventional Neurology Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Interventional Neurology Devices Average Price (K USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Interventional Neurology Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Interventional Neurology Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Interventional Neurology Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interventional Neurology Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Interventional Neurology Devices Sales by Region (2016-2021) & (Units)
Table 16. Global Interventional Neurology Devices Sales Market Share by Region (2016-2021)
Table 17. Global Interventional Neurology Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Interventional Neurology Devices Sales by Country (2016-2021) & (Units)
Table 19. North America Interventional Neurology Devices Sales Market Share by Country (2016-2021)
Table 20. North America Interventional Neurology Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Interventional Neurology Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Interventional Neurology Devices Sales by Country (2016-2021) & (Units)
Table 23. Europe Interventional Neurology Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Interventional Neurology Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Interventional Neurology Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Interventional Neurology Devices Sales by Region (2016-2021) & (Units)
Table 27. Asia Pacific Interventional Neurology Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Interventional Neurology Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Interventional Neurology Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Interventional Neurology Devices Sales by Country (2016-2021) & (Units)
Table 31. Latin America Interventional Neurology Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Interventional Neurology Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Interventional Neurology Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Interventional Neurology Devices Sales by Country (2016-2021) & (Units)
Table 35. Middle East and Africa Interventional Neurology Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Interventional Neurology Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Interventional Neurology Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Interventional Neurology Devices Sales (Units) by Type (2016-2021)
Table 39. Global Interventional Neurology Devices Sales Market Share by Type (2016-2021)
Table 40. Global Interventional Neurology Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Interventional Neurology Devices Revenue Share by Type (2016-2021)
Table 42. Global Interventional Neurology Devices Price (K USD/Unit) by Type (2016-2021)
Table 43. Global Interventional Neurology Devices Sales (Units) by Application (2016-2021)
Table 44. Global Interventional Neurology Devices Sales Market Share by Application (2016-2021)
Table 45. Global Interventional Neurology Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Interventional Neurology Devices Revenue Share by Application (2016-2021)
Table 47. Global Interventional Neurology Devices Price (K USD/Unit) by Application (2016-2021)
Table 48. Abbott Corporation Information
Table 49. Abbott Description and Business Overview
Table 50. Abbott Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 51. Abbott Interventional Neurology Devices Product
Table 52. Abbott Recent Developments/Updates
Table 53. DePuy Synthes Corporation Information
Table 54. DePuy Synthes Description and Business Overview
Table 55. DePuy Synthes Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 56. DePuy Synthes Interventional Neurology Devices Product
Table 57. DePuy Synthes Recent Developments/Updates
Table 58. Medtronic Corporation Information
Table 59. Medtronic Description and Business Overview
Table 60. Medtronic Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 61. Medtronic Interventional Neurology Devices Product
Table 62. Medtronic Recent Developments/Updates
Table 63. Stryker Corporation Information
Table 64. Stryker Description and Business Overview
Table 65. Stryker Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 66. Stryker Interventional Neurology Devices Product
Table 67. Stryker Recent Developments/Updates
Table 68. Terumo Corporation Information
Table 69. Terumo Description and Business Overview
Table 70. Terumo Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 71. Terumo Interventional Neurology Devices Product
Table 72. Terumo Recent Developments/Updates
Table 73. Acandis Corporation Information
Table 74. Acandis Description and Business Overview
Table 75. Acandis Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 76. Acandis Interventional Neurology Devices Product
Table 77. Acandis Recent Developments/Updates
Table 78. Bayer Corporation Information
Table 79. Bayer Description and Business Overview
Table 80. Bayer Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 81. Bayer Interventional Neurology Devices Product
Table 82. Bayer Recent Developments/Updates
Table 83. Boston Scientific Corporation Information
Table 84. Boston Scientific Description and Business Overview
Table 85. Boston Scientific Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 86. Boston Scientific Interventional Neurology Devices Product
Table 87. Boston Scientific Recent Developments/Updates
Table 88. Biosensors International Corporation Information
Table 89. Biosensors International Description and Business Overview
Table 90. Biosensors International Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 91. Biosensors International Interventional Neurology Devices Product
Table 92. Biosensors International Recent Developments/Updates
Table 93. evonos Corporation Information
Table 94. evonos Description and Business Overview
Table 95. evonos Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 96. evonos Interventional Neurology Devices Product
Table 97. evonos Recent Developments/Updates
Table 98. Merit Medical Systems Corporation Information
Table 99. Merit Medical Systems Description and Business Overview
Table 100. Merit Medical Systems Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 101. Merit Medical Systems Interventional Neurology Devices Product
Table 102. Merit Medical Systems Recent Developments/Updates
Table 103. MicroPort Scientific Corporation Information
Table 104. MicroPort Scientific Description and Business Overview
Table 105. MicroPort Scientific Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 106. MicroPort Scientific Interventional Neurology Devices Product
Table 107. MicroPort Scientific Recent Developments/Updates
Table 108. Neurosign Corporation Information
Table 109. Neurosign Description and Business Overview
Table 110. Neurosign Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 111. Neurosign Interventional Neurology Devices Product
Table 112. Neurosign Recent Developments/Updates
Table 113. Penumbra Corporation Information
Table 114. Penumbra Description and Business Overview
Table 115. Penumbra Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 116. Penumbra Interventional Neurology Devices Product
Table 117. Penumbra Recent Developments/Updates
Table 118. Spiegelberg Corporation Information
Table 119. Spiegelberg Description and Business Overview
Table 120. Spiegelberg Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 121. Spiegelberg Interventional Neurology Devices Product
Table 122. Spiegelberg Recent Developments/Updates
Table 123. Surtex Instruments Corporation Information
Table 124. Surtex Instruments Description and Business Overview
Table 125. Surtex Instruments Interventional Neurology Devices Sales (Units), Revenue (Million US$), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 126. Surtex Instruments Interventional Neurology Devices Product
Table 127. Surtex Instruments Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Interventional Neurology Devices Distributors List
Table 131. Interventional Neurology Devices Customers List
Table 132. Interventional Neurology Devices Market Trends
Table 133. Interventional Neurology Devices Growth Drivers
Table 134. Interventional Neurology Devices Market Challenges
Table 135. Interventional Neurology Devices Market Restraints
Table 136. Global Interventional Neurology Devices Sales Forecast by Type (2022-2027) & (Units)
Table 137. Global Interventional Neurology Devices Sales Market Share Forecast by Type (2022-2027)
Table 138. Global Interventional Neurology Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 139. Global Interventional Neurology Devices Revenue Market Share Forecast by Type (2022-2027)
Table 140. Global Interventional Neurology Devices Sales Forecast by Application (2022-2027) & (Units)
Table 141. Global Interventional Neurology Devices Sales Market Share Forecast by Application (2022-2027)
Table 142. Global Interventional Neurology Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 143. Global Interventional Neurology Devices Revenue Market Share Forecast by Application (2022-2027)
Table 144. Global Interventional Neurology Devices Sales Forecast by Region (2022-2027) & (Units)
Table 145. Global Interventional Neurology Devices Sales Market Share Forecast by Region (2022-2027)
Table 146. Global Interventional Neurology Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 147. Global Interventional Neurology Devices Revenue Market Share Forecast by Region (2022-2027)
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Interventional Neurology Devices
Figure 2. Global Interventional Neurology Devices Market Share by Type in 2020 & 2027
Figure 3. Aneurysm Coiling and Embolization Devices Product Picture
Figure 4. Angioplasty Devices Product Picture
Figure 5. Micro Support Devices Product Picture
Figure 6. Neurothrombectomy Devices Product Picture
Figure 7. Global Interventional Neurology Devices Market Share by Application in 2020 & 2027
Figure 8. Hospital
Figure 9. Ambulatory Care Centers
Figure 10. Others
Figure 11. Global Interventional Neurology Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Interventional Neurology Devices Market Size 2016-2027 (US$ Million)
Figure 13. Global Interventional Neurology Devices Sales 2016-2027 (Units)
Figure 14. Global Interventional Neurology Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Interventional Neurology Devices Sales Share by Manufacturers in 2020
Figure 16. Global Interventional Neurology Devices Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Interventional Neurology Devices Players: Market Share by Revenue in 2020
Figure 18. Interventional Neurology Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Interventional Neurology Devices Sales Market Share by Region (2016-2021)
Figure 20. Global Interventional Neurology Devices Sales Market Share by Region in 2020
Figure 21. Global Interventional Neurology Devices Revenue Market Share by Region (2016-2021)
Figure 22. Global Interventional Neurology Devices Revenue Market Share by Region in 2020
Figure 23. U.S. Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Interventional Neurology Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Interventional Neurology Devices by Type (2016-2021)
Figure 48. Sales Market Share of Interventional Neurology Devices by Application (2016-2021)
Figure 49. Sales Market Share of Interventional Neurology Devices by Application in 2020
Figure 50. Revenue Share of Interventional Neurology Devices by Application (2016-2021)
Figure 51. Revenue Share of Interventional Neurology Devices by Application in 2020
Figure 52. Manufacturing Cost Structure of Interventional Neurology Devices
Figure 53. Manufacturing Process Analysis of Interventional Neurology Devices
Figure 54. Interventional Neurology Devices Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed